Clinical outcomes after transcatheter aortic valve replacement using valve Academic Research Consortium definitions: A weighted meta-analysis of 3,519 patients from 16 studies

Journal of the American College of Cardiology

Volumn 59, Issue 25, 2012, Pages 2317-2326

  Généreux, Philippe ^a,b   Head, Stuart J ^c   Van Mieghem, Nicolas M ^c   Kodali, Susheel ^a   Kirtane, Ajay J ^a   Xu, Ke ^a   Smith, Craig ^a   Serruys, Patrick W ^c   Kappetein, A Pieter ^c   Leon, Martin B ^a  

^a NewYork Presbyterian Hospital   (United States)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

aortic stenosis; TAVI; TAVR; VARC

Indexed keywords

TROPONIN;

ACUTE KIDNEY FAILURE; AGED; AORTA DISSECTION; AORTA RUPTURE; AORTA VALVE REGURGITATION; ARTICLE; BLEEDING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; ENDOCARDITIS; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RUPTURE; HEART TAMPONADE; HEART VALVE PROSTHESIS; HEART VENTRICLE PERFORATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDICAL SOCIETY; META ANALYSIS; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; PROTEIN BLOOD LEVEL; STROKE; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC VALVE; AORTIC VALVE STENOSIS; CONFOUNDING FACTORS (EPIDEMIOLOGY); HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MYOCARDIAL INFARCTION; PACEMAKER, ARTIFICIAL; STROKE; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862181480     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.022     Document Type: Article

References (47)

1. A. Cribier, H. Eltchaninoff, A. Bash Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circulation 106 2002 3006 3008 (Pubitemid 35440280)
2. A. Cribier, H. Eltchaninoff, C. Tron Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis J Am Coll Cardiol 43 2004 698 703 (Pubitemid 38229547)
3. A. Cribier, H. Eltchaninoff, C. Tron Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience J Am Coll Cardiol 47 2006 1214 1223
4. E. Grube, G. Schuler, L. Buellesfeld Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome J Am Coll Cardiol 50 2007 69 76 (Pubitemid 46970878)
5. N. Piazza, E. Grube, U. Gerckens Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval EuroIntervention 4 2008 242 249
6. J.G. Webb, S. Pasupati, K. Humphries Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis Circulation 116 2007 755 763 (Pubitemid 47255993)
7. J. Rodes-Cabau, J.G. Webb, A. Cheung Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience J Am Coll Cardiol 55 2010 1080 1090
8. M. Thomas, G. Schymik, T. Walther Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve Circulation 122 2010 62 69
9. L. Buellesfeld, U. Gerckens, G. Schuler 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis J Am Coll Cardiol 57 2011 1650 1657
10. A. D'Onofrio, P. Rubino, M. Fusari Clinical and hemodynamic outcomes of "all-comers" undergoing transapical aortic valve implantation: results from the Italian Registry of Transapical Aortic Valve Implantation (I-TA) J Thorac Cardiovasc Surg 142 2011 768 775
11. H. Eltchaninoff, A. Prat, M. Gilard Transcatheter aortic valve implantation: early results of the FRANCE (FRrench Aortic National CoreCalve and Edwards) registry Eur Heart J 32 2011 191 197
12. M. Gotzmann, W. Bojara, M. Lindstaedt One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis Am J Cardiol 107 2011 1687 1692
13. J.M. Bosmans, J. Kefer, B. De Bruyne Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry Interact Cardiovasc Thorac Surg 12 2011 762 767
14. M.B. Leon, N. Piazza, E. Nikolsky Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
15. R. DerSimonian, N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
16. A. Liberati, D.G. Altman, J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
17. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
18. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, D.F. Stroup Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement Quality of reporting of meta-analyses Lancet 354 1999 1896 1900
19. D.F. Stroup, J.A. Berlin, S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting Meta-analysis of observational studies in epidemiology (moose) group JAMA 283 2000 2008 2012 (Pubitemid 30214957)
20. G.L. Buchanan, A. Chieffo, M. Montorfano The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN and Medtronic CoreValve revalving system(r) devices: the Milan registry EuroIntervention 7 2011 556 563
21. E. Grube, C. Naber, A. Abizaid Feasibility of transcatheter aortic valve implantation without balloon pre-dilation a pilot study J Am Coll Cardiol Intv 4 2011 751 757
22. R. Gurvitch, S. Toggweiler, A.B. Willson Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines EuroIntervention 7 2011 41 48
23. K. Hayashida, T. Lefevre, B. Chevalier Transfemoral aortic valve implantation new criteria to predict vascular complications J Am Coll Cardiol Intv 4 2011 851 858
24. R. Lange, S. Bleiziffer, N. Piazza Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients Eur J Cardiothorac Surg 40 2011 1105 1113
25. M. Mussardo, A. Latib, A. Chieffo Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the SAPIEN XT as compared with the Edwards SAPIEN valve J Am Coll Cardiol Intv 4 2011 743 750
26. R.J. Nuis, N.M. van Mieghem, R.M. van der Boon Effect of experience on results of transcatheter aortic valve implantation using a Medtronic CoreValve system Am J Cardiol 107 2011 1824 1829
27. B.E. Stahli, R. Bunzli, J. Grunenfelder Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC) J Invasive Cardiol 23 2011 307 312
28. P. Wenaweser, T. Pilgrim, E. Guerios Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation EuroIntervention 7 2011 541 548
29. G.P. Ussia, M. Scarabelli, M. Mule Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation Am J Cardiol 108 2011 1772 1776
30. R. Bagur, J. Rodes-Cabau, E. Dumont Exercise capacity in patients with severe symptomatic aortic stenosis before and six months after transcatheter aortic valve implantation Am J Cardiol 108 2011 258 264
31. B. Dehédin, P.G. Guinot, H. Ibrahim Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients J Cardiothorac Vasc Anesth 25 2011 1036 1043
32. M. Gotzmann, A. Pljakic, W. Bojara Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response Am Heart J 162 2011 238 245.e1
33. M.B. Leon, C.R. Smith, M. Mack Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
34. C.R. Smith, M.B. Leon, M.J. Mack Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
35. K. Ikeda, M. Ho, M. Kawahara Valve Academic Research Consortium consensus report: the pharmaceutical and medical devices agency perspective J Am Coll Cardiol 58 2011 777
36. S.H. Ewe, M. Muratori, V. Delgado Hemodynamic and clinical impact of prosthesis-patient mismatch after transcatheter aortic valve implantation J Am Coll Cardiol 58 2011 1910 1918
37. M.A. Clavel, J. Rodes-Cabau, E. Dumont Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography J Am Coll Cardiol Img 4 2011 1053 1062
38. M. Thomas, G. Schymik, T. Walther One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve Circulation 124 2011 425 433
39. J. Rodes-Cabau, M. Gutierrez, R. Bagur Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation J Am Coll Cardiol 57 2011 1988 1999
40. T. Lefevre, A.P. Kappetein, E. Wolner One year follow-up of the multi-centre European PARTNER transcatheter heart valve study Eur Heart J 32 2011 148 157
41. A.S. Petronio, M. De Carlo, F. Bedogni Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system Circ Cardiovasc Interv 3 2010 359 366
42. P. Généreux, S. Kodali, M.B. Leon Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation J Am Coll Cardiol Intv 4 2011 861 867
43. T. Walther, M.T. Kasimir, M. Doss One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation Eur J Cardiothorac Surg 39 2011 532 537
44. C. Fraccaro, M. Napodano, G. Tarantini Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system J Am Coll Cardiol Intv 2 2009 828 833
45. H. Ruge, R. Lange, S. Bleiziffer First successful aortic valve implantation with the CoreValve revalving system via right subclavian artery access: a case report Heart Surg Forum 11 2008 E323 E324
46. V. Bapat, M.Z. Khawaja, R. Attia Transaortic transcatheter aortic valve implantation using Edwards SAPIEN valve: a novel approach Catheter Cardiovasc Interv 79 2012 733 740
47. D. Himbert, F. Descoutures, N. Al-Attar Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis J Am Coll Cardiol 54 2009 303 311